AlphaFold predicted structure
F3 · P13726

Mean pLDDT
84.8/ 100
Confident
295 residues
Confidence breakdown
- Very high(≥ 90)68%
- Confident(70–90)11%
- Low(50–70)7%
- Very low(< 50)14%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
coagulation factor III, tissue factor
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Thrombophilia with a likely monogenic cause
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomalcervical cancer
cancer
neoplasm
placental abruption
spontaneous coronary artery dissection
macular degeneration
ovarian cancer
retinitis pigmentosa
rheumatoid arthritis
colorectal cancer
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Tissue factor
Initiates blood coagulation by forming a complex with circulating factor VII or VIIa. The [TF:VIIa] complex activates factors IX or X by specific limited proteolysis. TF plays a role in normal hemostasis by initiating the cell-surface assembly and propagation of the coagulation protease cascade
F3 · P13726

Mean pLDDT
84.8/ 100
Confident
295 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0